Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Breast MRI of pure ductal carcinoma in situ: sensitivity of diagnosis and influence of lesion characteristics.

Baur A, Bahrs SD, Speck S, Wietek BM, Krämer B, Vogel U, Claussen CD, Siegmann-Luz KC.

Eur J Radiol. 2013 Oct;82(10):1731-7. doi: 10.1016/j.ejrad.2013.05.002. Epub 2013 Jun 3.

PMID:
23743052
2.

BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.

Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD.

Breast J. 2007 Nov-Dec;13(6):545-50.

PMID:
17983393
3.

Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?

Jiang L, Zhou Y, Wang Z, Lu X, Chen M, Zhou C.

Eur J Radiol. 2013 Sep;82(9):1404-9. doi: 10.1016/j.ejrad.2013.03.006. Epub 2013 Mar 27.

PMID:
23540946
4.

BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.

Tozaki M.

Breast Cancer. 2013 Jan;20(1):13-20. doi: 10.1007/s12282-011-0312-3. Epub 2011 Nov 23.

PMID:
22109641
5.

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.

Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH.

Lancet. 2007 Aug 11;370(9586):485-92.

PMID:
17693177
6.

MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.

Huang YT, Cheung YC, Lo YF, Ueng SH, Kuo WL, Chen SC.

Acta Radiol. 2011 Dec 1;52(10):1064-8. doi: 10.1258/ar.2011.110213. Epub 2011 Oct 3.

PMID:
21969708
7.

[MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].

Yu QX, Chen XS, Wu JY, Han BS, He JR, Zhu L, Chen WG, Li YF, Tan L, Chai WM, Wang DB, Fei XC, Yuan F, Jin XL, Shen KW, Li HW.

Zhonghua Wai Ke Za Zhi. 2013 Jan 1;51(1):26-9. Chinese.

PMID:
23578423
8.

MRI morphological classification of ductal carcinoma in situ (DCIS) correlating with different biological behavior.

Liu H, Peng W.

Eur J Radiol. 2012 Feb;81(2):214-7. doi: 10.1016/j.ejrad.2010.12.084. Epub 2011 Feb 5.

PMID:
21296513
9.

The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.

Goto M, Yuen S, Akazawa K, Nishida K, Konishi E, Kajihara M, Shinkura N, Yamada K.

Eur Radiol. 2012 Jun;22(6):1255-64. doi: 10.1007/s00330-011-2357-2. Epub 2011 Dec 30.

PMID:
22205445
10.

Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?

Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E.

Clin Radiol. 2009 Dec;64(12):1166-74. doi: 10.1016/j.crad.2009.08.003. Epub 2009 Oct 21.

PMID:
19913125
11.

The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.

Kim JS, Lee SM, Cha ES.

Acta Radiol. 2014 Jul;55(6):668-75. doi: 10.1177/0284185113505086. Epub 2013 Sep 16.

PMID:
24043881
12.

Ductal carcinoma in situ: is there a role for MRI?

Zuiani C, Francescutti GE, Londero V, Zunnui I, Bazzocchi M.

J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):89-95.

PMID:
12585661
13.

The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.

Miyashita M, Amano G, Ishida T, Tamaki K, Uchimura F, Ono T, Yajima M, Kuriya Y, Ohuchi N.

Jpn J Clin Oncol. 2013 Jun;43(6):654-63. doi: 10.1093/jjco/hyt055. Epub 2013 Apr 16.

PMID:
23592884
14.

MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?

Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M.

Acta Radiol. 2013 Sep;54(7):742-8. doi: 10.1177/0284185113484640. Epub 2013 Apr 30.

PMID:
23588154
15.

Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.

Papantoniou V, Sotiropoulou E, Valsamaki P, Tsaroucha A, Sotiropoulou M, Ptohis N, Stipsanelli A, Dimitrakakis K, Marinopoulos S, Tsiouris S, Antsaklis A.

Breast Cancer. 2011 Oct;18(4):286-91. doi: 10.1007/s12282-009-0192-y. Epub 2010 Feb 9.

PMID:
20143189
16.

Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.

Rahbar H, Partridge SC, Eby PR, Demartini WB, Gutierrez RL, Peacock S, Lehman CD.

Eur Radiol. 2011 Sep;21(9):2011-9. doi: 10.1007/s00330-011-2140-4. Epub 2011 May 12.

PMID:
21562806
17.

Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).

Badan GM, Piato S, Roveda D Júnior, de Faria Castro Fleury E.

Eur J Radiol. 2016 Oct;85(10):1701-7. doi: 10.1016/j.ejrad.2016.07.010. Epub 2016 Jul 19.

PMID:
27666605
18.

Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.

Nadrljanski M, Maksimović R, Plešinac-Karapandžić V, Nikitović M, Marković-Vasiljković B, Milošević Z.

Eur J Radiol. 2014 Aug;83(8):1363-7. doi: 10.1016/j.ejrad.2014.05.006. Epub 2014 May 16.

PMID:
24894697
19.

MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients.

Marcotte-Bloch C, Balu-Maestro C, Chamorey E, Ettore F, Raoust I, Flipo B, Chapellier C.

Eur J Radiol. 2011 Mar;77(3):462-7. doi: 10.1016/j.ejrad.2009.09.003. Epub 2009 Nov 6.

PMID:
19896789

Supplemental Content

Support Center